How we treat

This Journal of Hematology & Oncology series will focus on guidelines, consensus, and multidisciplinary approaches on cancers and blood disorders. All submissions to this series need to be pre-approved. Prospective authors should contact the Journal Development Manager for pre-approval with the outline of their paper, the lead author name, and institution. Manuscripts sponsored by pharmaceutical companies will not be considered.

Articles published in the collection have already gone through the systematic peer review process of the journal.